Mesenteric Tumor Causing Brain Lesion
Author Information
Author(s): Tarun Puri, Gunabushanam Gowthaman, Monica Malik, Shikha Goyal, Anup K Das, Pramod K Julka, Goura K Rath
Primary Institution: All India Institute of Medical Sciences, New Delhi, India
Conclusion
The study highlights the importance of testing for CD117 in sarcomas of unknown origin to identify gastrointestinal stromal tumors (GIST).
Supporting Evidence
- The patient initially presented with a brain lesion that was later identified as a metastasis from a mesenteric tumor.
- Immunohistochemistry testing for CD117 was crucial in diagnosing the GIST.
- The patient showed a good initial response to imatinib treatment.
Takeaway
A man had a tumor in his belly that spread to his brain, and doctors found out it was a special type of tumor called GIST after he didn't get better with regular treatment.
Methodology
The case of a 42-year-old male with a solitary intracranial lesion was reported, and diagnostic tests were conducted to identify the tumor type.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
One 42-year-old male patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website